APELLIS PHARMACEUTICALS INC's ticker is and the CUSIP is 03753U956. A total of 3 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,349,592 | +45.6% | 429,800 | +248.6% | 0.06% | +52.8% |
| Q2 2023 | $11,232,630 | +211.3% | 123,300 | +125.4% | 0.04% | +176.9% |
| Q1 2023 | $3,608,012 | -60.4% | 54,700 | -68.9% | 0.01% | -38.1% |
| Q4 2022 | $9,100,960 | +107.5% | 176,000 | +174.1% | 0.02% | +133.3% |
| Q3 2022 | $4,385,000 | +0.2% | 64,200 | -33.7% | 0.01% | +28.6% |
| Q2 2022 | $4,377,000 | -41.7% | 96,800 | -34.5% | 0.01% | 0.0% |
| Q1 2022 | $7,505,000 | +64.5% | 147,700 | +53.1% | 0.01% | +75.0% |
| Q4 2021 | $4,563,000 | -38.9% | 96,500 | -57.4% | 0.00% | -50.0% |
| Q3 2021 | $7,472,000 | +237.8% | 226,700 | +547.7% | 0.01% | +166.7% |
| Q2 2021 | $2,212,000 | +995.0% | 35,000 | +644.7% | 0.00% | – |
| Q1 2021 | $202,000 | -41.1% | 4,700 | -21.7% | 0.00% | -100.0% |
| Q4 2020 | $343,000 | +54.5% | 6,000 | -11.8% | 0.00% | 0.0% |
| Q2 2020 | $222,000 | +22.0% | 6,800 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $182,000 | -71.4% | 6,800 | -67.3% | 0.00% | -75.0% |
| Q4 2019 | $637,000 | – | 20,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 6,800 | $222,000 | 0.00% |
| SIMPLEX TRADING, LLC | 166 | $542,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |